Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer.

Zhou, Jinmei; Wu, Xuexue; Zhang, Huiqiang; Wang, Xiaobo; Yuan, Yang; Zhang, Shaohua; Jiang, Zefei; Wang, Tao

Zhou, Jinmei; Wu, Xuexue; Zhang, Huiqiang; Wang, Xiaobo; Yuan, Yang; Zhang, Shaohua; Jiang, Zefei; Wang, Tao.

Afiliación

Zhou J; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Wu X; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhang H; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Wang X; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Yuan Y; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhang S; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Jiang Z; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: jiangzefei@csco.org.cn.
Wang T; Breast Cancer Department of Oncology Institute, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; Anhui Medical University, Hefei, China; Southern Medical University, Guangzhou, China. Electronic address: wangtao733073@163.com.

Breast ; 66: 255-261, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36375386

Asunto(s)

Neoplasias de la Mama; Humanos; Femenino; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/genética; Neoplasias de la Mama/patología; Estudios Retrospectivos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Receptor ErbB-2/genética; Receptores de Estrógenos; Quinasa 4 Dependiente de la Ciclina/genética; Quinasa 6 Dependiente de la Ciclina/genética

Palabras clave

CDK4/6 inhibitor; Endocrine therapy; Hormone receptor-positive; Metastatic breast cancer; Tucidinostat

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google